BRAF and melanoma: Recent studies have shown that histone deacetylase (HDAC) and mutant BRAF (v-Raf murine sarcoma viral oncogene homolog B1) inhibitors synergistically kill melanoma cell lines with activating mutations in BRAF by induction of necrosis [91].